NYSE: BHCBausch Health Companies Inc Stock Ownership - Who owns Bausch Health Companies?
Insider buying vs selling
Have Bausch Health Companies Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paulson Co Inc | 10% Owner | 2025-11-25 | 2,500,000 | $6.25 | $15.63MBuy |
| Seana Carson | EVP General Counsel | 2025-09-08 | 13,370 | $7.31 | $97.73kSell |
| Seana Carson | EVP General Counsel | 2025-09-05 | 51,337 | $7.35 | $377.33kSell |
| Frank D. Lee | Director | 2025-08-21 | 15,912 | $7.66 | $121.89kSell |
| John Paulson | Director | 2025-08-14 | 34,721,118 | $9.00 | $312.49MBuy |
| John Paulson | Director | 2025-08-13 | 86,409 | $7.06 | $610.05kBuy |
| John Paulson | Director | 2025-08-12 | 1,156,640 | $6.88 | $7.96MBuy |
| John Paulson | Director | 2025-08-11 | 2,000,000 | $6.35 | $12.70MBuy |
| Aimee J. Lenar | EVP US Pharma | 2025-07-15 | 22,736 | $6.42 | $145.97kSell |
| John Paulson | Director | 2025-06-13 | 3,564,059 | $5.94 | $21.17MBuy |
BHC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BHC insiders and whales buy or sell their stock.
BHC Shareholders
What type of owners hold Bausch Health Companies Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| John Paulson | 25.76% | 95,429,389 | $553.49M | Insider |
| Paulson Co Inc | 19.77% | 73,255,869 | $424.88M | Insider |
| Paulson Co Inc | 19.10% | 70,755,869 | $410.38M | Institution |
| Goldentree Asset Management LP | 9.40% | 34,833,431 | $202.03M | Institution |
| David Robert Hale | 5.10% | 18,908,638 | $109.67M | Insider |
| Valueact Holdings LP | 4.84% | 17,933,228 | $104.01M | Insider |
| Nomura Holdings Inc | 4.24% | 15,708,085 | $91.11M | Institution |
| Jeffrey W. Ubben | 3.76% | 13,934,468 | $80.82M | Insider |
| Healthcare Of Ontario Pension Plan Trust Fund | 3.51% | 13,000,000 | $75.40M | Institution |
| Vanguard Group Inc | 3.30% | 12,241,072 | $71.00M | Institution |
BHC vs Pharmaceutical Stocks
Bausch Health Companies Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.